09/03/2015 - 9:41am

 The drug, a biosimilar version of Amgen’s Neupogen, is the first biosimilar drug to launch in the U.S.

09/02/2015 - 10:39am

Par Pharmaceutical on Wednesday announced that it has begun shipping its generic version of AbbVie’s AnroGel (testosterone gel 1%) in 2.5-g and 5-g foil packets.

09/02/2015 - 9:44am

he campaign is being undertaken in partnership with the American Chronic Pain Association, the Pain Community, the U.S. Pain Foundation and the American Academy of Pain Management.

09/01/2015 - 3:08pm

PrescribeMedicare is meant to serve as a tool for patients in 2016 when open enrollment for plan choices begins.

08/31/2015 - 3:31pm

The guidance was outlined in a blog post by Janet Woodcock, director of the FDA’s center for drug evaluation and research, and Karen Midthum, director of the FDA’s center for biologics evaluation and research.

08/28/2015 - 10:31am

Mylan will now move forward with its plans to tender a formal offer directly to Perrigo’s shareholders. 

08/27/2015 - 4:53pm

Aurobindo Pharma Limited announced Thursday that it had received approval from the Food and Drug Administration for its entecavir tablets in 0.5- and 1-mg dosage strengths. 

08/26/2015 - 2:30pm

Mylan this week announced the launch of its generic version of Pfizer’s Zosyn (piperacillin and tazobactam) injection.

08/25/2015 - 1:50pm
According to GlobalData’s report, the market is set to grow from $29.4 billion in 2014 to $47.9 billion by 2020, which represents a compound annual growth rate of 8.5%.